繁體版 / 簡體版
 
R&D PORTFOLIO
/ HERBIRON

HERBIRON

Indication
Relieving symptoms of iron deficiency anemia and menstrual discomfort
Ingredient
Si Wu (Rehmanniae Radix, Chuanxiong Rhizoma, Angelicae Sinensis Radix, Paeonia Alba Radix) plus ferrous Bisglycinate
Dosage
50 ml twice daily on an empty stomach before meals
Product Advantages
Significantly elevate Hemoglobin, Mean corpuscular volume and Serum ferritin
Status
Post-market drug
  • Herbiron in accordance with the concept of Chinese and Western cultures, is composed of Chinese herbal medicine and well-known study ferrous Bisglycinate.
  • Ferrous Bisglycinate is easily absorbed by the body, can increase iron utilization, more than other iron supplements.
  • Herbiron was approved as new drug by Ministry of Health and Welfare (MOHW) in 2013
  • The clinical efficacy of Herbiron was confirmed in a phase III trial. Herbiron significantly improved the anemia symptoms caused by iron deficiency in premenopausal females and relieved Dysmenorrhea.
  • The safety of Herbiron was confirmed in a phase III trial. The incidence of gastrointestinal side effects in subjects treated with Herbiron was significantly reduced when compared to that in subjects treated with ferrous sulfate.

Phase III Clinical Results

Serum ferritin, Hemoglobin and the Mean corpuscular volume concentration increased significantly over time as compared to baseline (before drug use) (* p <0.0001)


好玩棋牌 股票分析群 有15万存款怎么理财 福建体育彩票11选五 贵州快3开奖快结果 河南十一选五开奖结果一定牛 18luck线上娱乐城百家乐 甘肃快3走势图彩王彩票 云南体彩11选五开奖结果今天 北京赛车计划人工 山东十一选五真准网